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Little is known about the cross-national general population
prevalence or correlates of personality disorders. The most
extensive data come from ten epidemiological surveys in the
USA1–10 and four in Europe11–14 that reported prevalence
estimates using DSM–III, DSM–III–R or DSM–IV15 criteria.
Prevalence estimates for any personality disorder in these studies
are in the range of 3.9–15.7%, other than one study based on a
sample of volunteers with obsessive–compulsive disorder and
their relatives.1 A number of these studies were limited to a
particular city,9,14 county2 or subpopulation.6 Median sample size
was small (less than 500 respondents) by the standards of
epidemiological studies. The aim of the present study is to address
these limitations by estimating prevalence and basic correlates of
DSM–IV personality disorder clusters from screening questions
included in epidemiological surveys in 13 countries that
participated in the World Health Organization (WHO) World
Mental Health (WMH) Survey Initiative.16
Method
Sample
The countries are widely distributed, including one in Asia
(China), two in Africa (Nigeria, South Africa), three in the
Americas (Colombia, Mexico, USA), one in the Middle East
(Lebanon), and six in Western Europe (Belgium, France,
Germany, Italy, The Netherlands, Spain) (online Table DS1). Six
of the countries are classified by the World Bank as less developed
(China, Colombia, Lebanon, Mexico, Nigeria, South Africa),17
and the others as developed.
All 13 surveys were conducted face to face by trained lay inter-
viewers using consistent procedures. The WMH interviewer train-
ing materials, interview schedule and respondent visual aids were
all translated from the original English version using standardised
WHO translation, back-translation and harmonisation protocols.
Consistent interviewer training procedures and quality control
procedures were used in all surveys. Informed consent was
obtained with procedures approved by the institutional review
board of the collaborating organisation in each country. Detailed
discussions of translation18 and field procedures19 are presented
elsewhere.
Respondents were selected from multi-stage household prob-
ability samples. Nine were nationally representative. The others
were representative of urban areas (Colombia, Mexico, China)
or regions (Nigeria). The weighted average response rate was
71.2%, ranging between 45.9% (France) and 87.7 % (Colombia).
Detailed discussion of sampling procedures is presented elsewhere.20
The WMH interview schedule was in two parts. All respon-
dents completed Part I, which contained core diagnostic assess-
ments. All Part I respondents who met criteria for any of these
anxiety, mood, externalising or substance use disorders, in
addition to a probability subsample of other Part I respondents,
were administered Part II, which assessed disorders of secondary
interest and a wide range of correlates. Questions on personality
disorders were included in Part II. These questions were further
restricted in the Western European surveys to a subsample of
married respondents who participated in a special ‘couples’
sample in which husbands and wives in the same family were
independently interviewed. Only one respondent was interviewed
per household in other cases.
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Background
Little is known about the cross-national population
prevalence or correlates of personality disorders.
Aims
To estimate prevalence and correlates of DSM–IV personality
disorder clusters in the World Health Organization World
Mental Health (WMH) Surveys.
Method
International Personality Disorder Examination (IPDE)
screening questions in 13 countries (n=21 162) were
calibrated to masked IPDE clinical diagnoses. Prevalence and
correlates were estimated using multiple imputation.
Results
Prevalence estimates are 6.1% (s.e. = 0.3) for any personality
disorder and 3.6% (s.e. = 0.3), 1.5% (s.e. = 0.1) and 2.7%
(s.e. = 0.2) for Clusters A, B and C respectively. Personality
disorders are significantly elevated among males, the
previously married (Cluster C), unemployed (Cluster C),
the young (Clusters A and B) and the poorly educated.
Personality disorders are highly comorbid with Axis I
disorders. Impairments associated with personality disorders
are only partially explained by comorbidity.
Conclusions
Personality disorders are relatively common disorders that
often co-occur with Axis I disorders and are associated with
significant role impairments beyond those due to
comorbidity.
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Questions on personality disorders were administered to
21 162 respondents across the 13 surveys. Cases of personality dis-
orders were weighted within each sample to adjust for differential
probability of selection and residual discrepancies between sample
and population sociodemographic/geographic distributions
(based on government census data). These weighted data were
used for the current analyses. Detailed discussion of weighting
procedures is presented elsewhere.20
Assessment of DSM–IV personality disorders
Personality disorders were assessed with 33 screening questions
from the International Personality Disorder Examination
(IPDE).21,22 These were selected in analyses of prior data5 as sig-
nificant predictors of either one or more of the three DSM–IV
personality disorder clusters (A, B and C) or the overall diagnosis
of any personality disorders (including personality disorders not
otherwise specified) assessed by a clinician-administered IPDE.
Responses to the questions were combined to create diagnoses
based on a calibration study of Part II respondents (n= 214) in the
US WMH survey, oversampling positive screens, who received a
clinician-administered IPDE over the telephone. Interviewers were
masked to screening question responses. An experienced IPDE
supervisor monitored tape-recordings of interviews and gave
feedback to prevent drift. Prior research shows that the IPDE
generates valid personality disorder diagnoses when administered
by telephone.23 DSM–IV diagnoses based on the clinical
interviews were generated for Clusters A, B, C and any personality
disorder. Predicted probabilities of these four diagnoses were then
assigned to each respondent based on responses to the screening
question using results of stepwise logistic regression in the clinical
reappraisal sample to generate predicted probabilities of each
diagnosis. Predictors included the screening questions, inform-
ation about respondent age and gender, and information about
other variables in the survey significantly related to the IPDE
diagnoses.
Prediction accuracy in the calibration sample was excellent in
all the equations, with area under the receiver operating charac-
teristic curve (AUC), a prevalence-free measure of classification
accuracy with a 0.5–1.0 range, of 0.94 for Cluster A, 0.92 for
Cluster B, 0.90 for Cluster C and 0.88 for any personality disorder.
These results are somewhat better than in an earlier analysis of US
data5 because a larger set of predictors were used in the WMH
equations. These predicted probabilities formed the basis of
further analyses, as described in more detail in the subsection
on analysis methods.
DSM–IV Axis I disorders
The WHO Composite International Diagnostic Interview (CIDI)
version 3.024 was used to assess Axis I DSM–IV disorders. The
CIDI is a fully structured lay-administered diagnostic interview.
Axis I disorders assessed included anxiety disorders (panic
disorder with or without agoraphobia, generalised anxiety
disorder, specific phobia, social phobia, agoraphobia without a
history of panic disorder, obsessive–compulsive disorder, post-
traumatic stress disorder, separation anxiety disorder); mood
disorders (major depressive disorder, bipolar disorder I or II,
dysthymic disorder); externalising disorders (oppositional–defiant
disorder, conduct disorder, attention-deficit hyperactivity dis-
order, intermittent explosive disorder); and substance use disorders
(alcohol and illicit drug use with or without dependence, nicotine
dependence). Organic exclusion rules and diagnostic hierarchy
rules were used in making diagnoses. Masked clinical reappraisal
interviews using the Structured Clinical Interview for DSM–IV25
with probability subsamples of respondents in several countries
found generally good concordance between DSM–IV/CIDI
diagnoses and diagnoses based on masked clinical reappraisal
interviews.26
Other correlates of personality disorders
Data on three other sets of variables are presented here: socio-
demographics, impairments in activities of daily living, and treat-
ment. Sociodemographics included gender, age (standardised to
a mean of 0 and variance of 1.0 in each country), education
(standardised the same way as age), employment status
(employed, retired, student, homemaker, other), income
(standardised the same way as age and education), and marital
status (married or cohabitating, previously married, never
married).
Impairments were assessed with the WHO Disability Assess-
ment Schedule (WHO–DAS),27 which evaluates functioning in
three domains of basic activities (self-care, mobility, cognition)
and two domains of instrumental activities (quality of productive
role performance, quality of social role performance) over a
30-day recall period. Each WHO–DAS dimension is scored on a
0–100 scale where 0 represents no impairment and 100 represents
complete impairment (i.e. unable to carry out the activity). To
facilitate interpretation, WHO–DAS scores were standardised to
a mean of 0 and variance of 1.0 in each country.
Treatment was assessed by asking each respondent if they had
sought professional help in the past 12 months for problems with
their emotions, nerves or substance use from a psychiatrist, other
mental health professional (e.g. clinical psychologist, psychiatric
social worker), general medical healthcare provider, human
services professional (e.g. religious counsellor, social worker seen
in at a social services agency), or a professional from the
complementary/alternative medicine sector (either receiving
treatment or participating in a self-help group). A visual list of
provider types was presented to respondents when asking this
question. Respondents were classified as seeking treatment if they
reported making at least one visit to any of these providers within
12 months of the interview.
Analysis methods
Multiple imputation28 was used to analyse predicted personality
disorder scores with a three-part simulation. First, ten pseudo-
samples (each n=214) were selected using stratified random
sampling with replacement from the 214 clinical reappraisal
interviews. Predicted probabilities for each personality disorder
outcome were estimated separately in each pseudo-sample,
resulting in each respondent having ten predicted probabilities
of each outcome.
Second, a random number between 0 and 1 was generated for
each predicted probability for each respondent. If the random
number was greater than the predicted probability, the individual
was classified as having the diagnosis. Reappraisal sample
participants had the same diagnostic classifications (either 0 or
1, depending on whether or not they had an IPDE diagnosis) in
each data-set.
Third, substantive analyses were carried out independently in
each pseudo-sample. The resulting ten sets of parameter estimates
(i.e. prevalence estimates, estimates of regression coefficients) were
averaged to obtain a best estimate of the parameters. The multiple
imputation variance of each averaged parameter estimate was
obtained by combining the mean of the variance across the ten
replications (i.e. the average within-replication variance) with
the variance of the parameter estimate across the replications
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(i.e. the between-replication variance). The standard error of the
parameter estimate was calculated by taking the square root of this
sum.
Multiple imputation prevalence estimates are unbiased to the
extent that the clinical reappraisal sample is representative.
Estimates of correlates are conservative to the extent that the
predictors in the imputation equations fail to capture the full
effects of the substantive correlates. When imputations are precise
(i.e. the AUC value is high), as in the current case, the precision of
the parameter estimates will approach the precision that would
have been achieved if personality disorder had been directly
assessed with IPDE interviews in the total sample. It is also
important to realise, however, that this approach assumes the
validity of the DSM–IV three-cluster model of personality dis-
orders. This model has not been supported in all empirical
studies,29,30 although it has in some.31,32
Personality disorder prevalence estimates and estimates of
treatment prevalence were calculated as the means of the ten
multiple imputation prevalence estimates. Associations of
personality disorders with sociodemographics, measures of
impairment and DSM–IV Axis I disorders were estimated using
logistic regression analysis, again with parameter estimates
averaged over the ten multiple imputation replications. Logistic
regression coefficients and their standard errors were
exponentiated and are reported as odds ratios and their 95%
confidence intervals.
Because the WMH sample design features weighting and
clustering, all parameter estimates were estimated using the
design-based Taylor series linearisation method33 implemented
in the SUDAAN software system for UNIX (Research Triangle
Park, North Caroline, USA). Significance tests of sets of coeffi-
cients were made using Wald w2-tests based on design-corrected
multiple imputation coefficient variance–covariance matrices.
Statistical significance was consistently evaluated using two-sided




The mean multiple imputation prevalence estimate of any
DSM–IV/IPDE personality disorder across samples (based on
sample sizes, not population sizes) is 6.1% (Table 1). These
estimates are lowest in Nigeria (2.7%) and Western Europe
(2.4%), and between 4.1% (e.g. China) and 7.9% (e.g. Colombia)
in other countries. Prevalence estimates for personality disorder
clusters average 3.6% for Cluster A, 1.5% for Cluster B and
2.7% for Cluster C. Cluster B is estimated to be the least prevalent
cluster in each survey, and Cluster A is estimated to be the most
prevalent in all countries other than Western Europe and the USA.
A consistent pattern of between-country differences holds for
all three clusters, with the lowest prevalence estimates in Nigeria
and Western Europe for Clusters A (1.6–1.1%), B (0.3–0.4%)
and C (0.9–1.2%). Co-occurrence between clusters is common,
especially between Clusters A and B, where the pooled (across
countries) odds ratio is 21.0 (95% CI 13.0–34.0). Odds ratios
for Clusters A–C and B–C are OR= 12.0 (95% CI 8.7–16.7) and
OR=12.1 (95% CI 7.9–18.5) respectively. This high co-occurrence
accounts for the sum of the prevalence estimates across clusters
substantially exceeding the prevalence of any personality disorder
in each country.
Sociodemographic correlates
Clusters A and C are significantly more prevalent among men
than women (Table 2). Clusters A and B are inversely related to
age. All three clusters are significantly and inversely related to
education. Employment status and marital status are
significantly related only to Cluster C (elevated among the
previously married and those who are either unemployed or dis-
abled). Most significant ORs are relatively modest in substantive
terms with the exception of OR= 5.0 between gender and Cluster
A. Within-country associations are generally consistent with those
in the pooled data. (Detailed results are available on request.)
Comorbidity with DSM–IV Axis I disorders
Each cluster is estimated to be positively and significantly
associated with each of the four classes of 12-month DSM–IVAxis
I disorders assessed in the WMH Surveys (Table 3). Odds ratios
are in the range of 2.8–14.5. The highest ORs involving anxiety
and mood disorders are with Cluster C (OR=11.4 and OR= 9.3
respectively). The highest ORs involving externalising and sub-
stance use disorders are with Cluster B (OR= 9.4 and OR= 14.5
respectively). Even stronger associations exist between personality
disorders and number of Axis I disorders, with a consistent dose–
response relationship between the number of Axis I disorders and
personality disorders. The ORs between having three or more Axis
I disorders (v. none) and a personality disorder are 9.7 for Cluster
A, 49.3 for Cluster B, 34.8 for Cluster C and 21.1 for any
personality disorder. Within-country associations are generally
consistent with those in the pooled data. (Detailed results are
available on request.)
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disorder, % (s.e.) n
Colombia 5.3 (0.6) 2.1 (0.4) 3.6 (0.5) 7.9 (1.1) 2381
Lebanon 4.2 (1.7) 1.7 (0.9) 2.9 (0.8) 6.2 (1.7) 1031
Mexico 4.6 (0.7) 1.6 (0.4) 2.4 (0.5) 6.1 (0.8) 2362
Nigeria 1.6 (0.5) 0.3 (0.2) 0.9 (0.3) 2.7 (0.7) 2143
People’s Republic of China 3.1 (0.7) 1.3 (0.7) 1.4 (0.6) 4.1 (1.1) 1628
South Africa 3.4 (0.5) 1.5 (0.3) 2.5 (0.5) 6.8 (0.7) 4315
USA 4.0 (0.4) 2.0 (0.3) 4.2 (0.4) 7.6b (0.5) 5692
Western Europea 1.1 (0.6) 0.4 (0.3) 1.2 (0.5) 2.4 (0.9) 1610
Total 3.6 (0.3) 1.5 (0.1) 2.7 (0.2) 6.1 (0.3) 21 162
IPDE, International Personality Disorder Examination; WMH, World Mental Health.
a. Includes Belgium, France, Germany, Italy and Spain.
b. This prevalence estimate differs from the estimate reported in a previous study based on US data5 owing to the use of an improved imputation equation in the current analysis.
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Over half (51.2%) of people with a personality disorder also
meet criteria for at least one Axis I disorder. This overlap is higher
for Clusters B (74.1%) and C (64.3%) than A (44.1%) (more
detailed results are available on request). About a sixth (16.5%)
of respondents with Axis I disorders, in comparison, are estimated
to meet criteria for one or more personality disorders. This
overlap is somewhat higher for externalising (27.6%) and mood
(23.6%) disorders than for anxiety (19.9%) or substance use
(18.8%) disorders (detailed results are available on request).
Impairments
Respondents with personality disorders have a significantly
elevated impairment in each of the WHO–DAS dimensions, with
effect sizes of 0.1–0.5 on standardised impairment scales (Table 4).
Associations of this size would be considered small to medium
using conventional criteria.35 The associations involving each
cluster are weakest with impairments in self-care (non-significant
associations of 0.1) and mobility (0.2–0.3) and stronger with
impairments in other domains (0.2–0.5). The latter associations
are strongest with Cluster C (all 0.5), less with Cluster B (0.4–
0.5) and least with Cluster A (0.2–0.3). The associations become
somewhat weaker (25–40% reduction in coefficients) when
controlled for comorbid Axis I disorders (detailed results are
available on request).
12-Month treatment
The proportion of people with personality disorders who
received treatment for mental disorders in the year before
interview varies substantially across countries, from 6.0% in
Nigeria to 37.3% in the USA (Table 5). Compared with
respondents without personality disorders, those with personality
disorders had elevated odds of treatment in every country
(OR= 1.5–4.1), although only three ORs are significant at the
0.05 level. Controls for comorbid Axis I disorders consistently
reduce the ORs (1.3–2.7), suggesting that treatment is often
obtained for Axis I disorders.
49
Table 2 Associations (ORs) of sociodemographic variables with DSM–IV/IPDE personality disorders pooled across the 13 WMH










Male 5.0*(5.0–10.0) 1.4 (1.0–2.0) 1.7* (1.3–2.5) 2.5* (2.5–3.3)
Female 1.0 1.0 1.0 1.0
Age 0.8* (0.7–1.0) 0.6* (0.5–0.7) 1.1 (0.9–1.4) 0.8* (0.7–0.9)
Education 0.8* (0.7–0.9) 0.7* (0.6–0.9) 0.8* (0.7–0.9) 0.8* (0.7–0.9)
Income 1.0 (0.8–1.2) 1.0 (0.8–1.2) 0.9 (0.6–1.2) 0.9 (0.7–1.1)
Marital status
Married or cohabiting 1.0 (0.6–1.5) 0.8 (0.4–1.4) 0.9 (0.7–1.3) 0.9 (0.7–1.1)
Previously marriedb 1.2 (0.6–2.2) 1.4 (0.7–2.6) 1.5* (1.0–2.4) 1.3 (0.9–2.0)
Never married 1.0 1.0 1.0 1.0
Employment
Employed 0.8 (0.6–1.0) 0.7 (0.4–1.3) 0.6* (0.4–0.9) 0.7* (0.6–0.9)
Student 0.8 (0.4–1.7) 0.6 (0.2–1.7) 0.6 (0.2–1.7) 0.6 (0.4–1.1)
Homemaker 0.8 (0.4–1.8) 0.6 (0.3–1.4) 0.6 (0.4–1.0) 0.7 (0.5–1.1)
Retired 0.8 (0.4–1.5) 0.5 (0.1–1.6) 0.5 (0.2–1.0) 0.6 (0.4–1.0)
Otherc 1.0 1.0 1.0 1.0
IPDE, International Personality Disorder Examination; WMH, World Mental Health.
a. Results are based on pooled within-country multiple imputation multivariate logistic regression models that used all sociodemographic variables simultaneously to predict
personality disorders. Age, education and income were coded as continuous variables standardised to have a mean of 0.0 and a variance of 1.0 in each country.
b. Separated, divorced or widowed.
c. Unemployed or disabled.
*Significant at the 0.05 level, using two-sided multiple imputation tests.
Table 3 Associations (ORs) of DSM–IV/IPDE personality disorders with 12-month DSM–IV/CIDI Axis I disorders pooled across









Any anxiety disorder 3.9* (2.9–5.3) 6.5* (4.3–9.6) 11.4* (8.4–15.5) 6.6* (5.3–8.2)
Any mood disorder 3.8* (2.9–4.9) 7.1* (5.0–10.0) 9.3* (7.1–12.2) 6.5* (4.9–8.6)
Any externalising disorder 5.2* (3.7–7.3) 9.4* (6.0–14.7) 5.9* (3.6–9.8) 5.2* (3.8–7.1)
Any substance use disorder 2.8* (2.0–3.9) 14.5* (8.5–24.7) 3.2* (2.3–4.4) 3.2* (2.3–4.4)
Any disorder 3.8* (2.9–4.9) 12.7* (7.3–21.9) 8.7* (6.3–12.0) 5.3*(4.4–6.4)
Number of Axis I disorders
Exactly one 2.7* (1.9–3.7) 6.2* (3.3–11.6) 4.6* (3.1–6.7) 3.1* (2.4–3.9)
Exactly two 4.4* (2.9–6.5) 17.8* (9.1–34.8) 11.8* (7.7–18.1) 6.8* (5.1–9.1)
Three or more 9.7* (6.2–15.1) 49.3* (24.1–101.0) 34.8* (22.2–54.5) 21.1* (16.0–27.9)
CIDI, Composite International Diagnostic Interview; IPDE, International Personality Disorder Examination; WMH, World Mental Health.
a. Odds ratio (OR) and 95% CI were estimated using multiple imputation logistic regression models in which personality disorders were treated as outcomes and Axis I disorders
were treated as predictors along with controls for age, gender and country. The predictive effects of anxiety, mood, externalising, substance use and any Axis I disorder were
estimated in separate equations, whereas the predictive effects of exactly one, exactly two, and three or more Axis I disorders were estimated in a single equation for each outcome.
*Significant at the 0.05 level, using two-sided multiple imputation tests.
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Discussion
Cross-national prevalence estimates of personality
disorders
The prevalence estimates reported here are lower than in most
previous studies that assessed personality disorders with
structured assessment instruments, where the median prevalence
of any personality disorder is 10.6%.35 However, two studies6,12
reported only modestly lower estimates than the WMH Surveys
and a third study7 found an overall prevalence estimate (7.3%)
only slightly higher than the 6.1% WMH estimate. The low
WMH estimate might reflect the fact that the IPDE generally
yields conservative estimates of personality disorder prevalence.5
Our finding that personality disorders, although significantly
associated with role impairment, are not associated with extreme
role impairment, argues against the possibility that the IPDE
picked up only severe cases and underestimated less severe cases
of personality disorders.
Another issue in comparing our results is that only a
minority of previous studies were based on relatively unrestricted
probability samples of the community.8,9,12,14 Most previous
personality disorder studies were opportunistic, assessing
prevalence in groups from local communities that had been
included in other studies. Some included controls, or even the
relatives of patients from the original study. The latter would be
expected to have a high prevalence of psychiatric morbidity,
including personality disorders. As noted in the last paragraph,
differences in prevalence estimates could also be due to differences
in instruments. Surveys using the Structured Interview for
DSM–III–R Personality (SIDP),36 for example, found consistently
high prevalence estimates for all personality disorders (13.4–
22.3%). This instrument effect raises currently unresolved
questions about the appropriate diagnostic thresholds for
personality disorders.
The multiple imputation method, which we used to estimate
prevalence, might have yielded downwardly biased prevalence
estimates. As multiple imputation is unbiased in estimating
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Table 4 Mean differences in impairments in daily activities in the 30 days before interview as assessed by the WHO–DAS among
respondents with DSM–IV/IPDE personality disorders compared with other respondents without (Part I) and with (Part II) comorbid











Self-care 0.1 (0.1) 0.1 (0.1) 0.2 (0.1) 0.1* (0.1)
Cognition 0.2* (0.1) 0.4* (0.1) 0.5* (0.1) 0.3* (0.1)
Mobility 0.2* (0.1) 0.2* (0.1) 0.3* (0.1) 0.2* (0.1)
Role functioning 0.2* (0.1) 0.5* (0.1) 0.5* (0.1) 0.4* (0.1)
Social interaction 0.3* (0.1) 0.4* (0.1) 0.5* (0.1) 0.3* (0.1)
Global 0.3* (0.1) 0.5* (0.1) 0.6* (0.1) 0.4* (0.1)
Part II
Self-care 0.1 (0.1) 0.1 (0.1) 0.2 (0.1) 0.1 (0.1)
Cognition 0.2* (0.1) 0.3* (0.1) 0.4* (0.1) 0.2* (0.1)
Mobility 0.1* (0.1) 0.1 (0.1) 0.2* (0.1) 0.1* (0.1)
Role functioning 0.1 (0.1) 0.3* (0.1) 0.3* (0.1) 0.2* (0.1)
Social interaction 0.2* (0.1) 0.3* (0.1) 0.4* (0.1) 0.3* (0.1)
Global 0.2* (0.1) 0.3* (0.1) 0.4* (0.1) 0.3* (0.1)
CIDI, Composite International Diagnostic Interview; IPDE, International Personality Disorder Examination; WHO–DAS, World Health Organization Disability Assessment Schedule;
WMH, World Mental Health.
a. South Africa was excluded from the analysis because the WHO–DAS was not included in the survey. Each WHO–DAS dimension was standardised to a mean of 0.0 and a variance
of 1.0 within each country. High scores represent more impairment. Separate linear regression equations were estmated for each cluster to predict scores on each WHO–DAS
dimension with controls for age, gender and country. The equations in Part II of the table also included controls for 12-month DSM–IV/CIDI Axis I disorders.
*Significant at the 0.05 level using two-sided multiple imputation tests.
Table 5 Treatment of emotional problems in the 12 months before interview among respondents with DSM–IV/IPDE personality
disorders in the WMH Surveysa
Respondents
Respondents in treatment v. respondents without
personality disorders, OR (95% CI)
Country in treatment, % (s.e.) Without Axis I disorders With Axis I disorders n
Colombia 11.6 (3.8) 2.8* (1.1–6.8) 1.7 (0.6–4.3) 2381
Lebanon 7.8 (4.0) 2.4 (0.5–10.7) 1.7 (0.4–8.0) 1031
Mexico 13.5 (3.6) 4.0* (1.8–8.6) 2.0 (0.9–4.4) 2362
Nigeria 6.0 (4.4) 4.1 (0.7–23.2) 2.7 (0.4–18.9) 2143
People’s Republic of China 6.6 (7.2) 1.8 (0.1–32.5) 1.3 (0.1–28.4) 1628
South Africa 19.9 (4.0) 1.5 (0.9–2.6) 1.3 (0.7–2.2) 4315
USA 37.3 (3.4) 3.4* (2.3–4.9) 1.7* (1.2–2.5) 5692
Western Europe 21.6 (13.5) 3.3 (0.5–21.4) 2.1 (0.3–17.4) 1610
IPDE, International Personality Disorder Examination; WMH, World Mental Health.
a. Odds ratio (OR) and 95% CI were estimated using multiple imputation logistic regression models in which a dummy for any personality disorder was treated as a predictor of
any 12-month treatment of emotional problems with controls for age and gender. The equations used to generate the results in the last column also included controls for 12-month
DSM–IV/ Composite International Diagnostic Interview Axis I disorders.
*Significant at the 0.05 level, two-sided test.
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prevalence when applied to a single population,28 the possibility of
bias implies that the imputation rules, which were based on
clinical calibration in the USA, might not be accurate in the other
WMH countries. To address this possibility, future cross-national
epidemiological surveys need to go beyond the exclusive use of
screening questions to administer full personality disorder clinical
interviews in community samples in multiple countries and to
carry out clinical reappraisal interviews in a substantial subsample
in each country.
The estimated cross-national variation in personality disorder
prevalence estimates also might reflect methodological factors.
The low prevalence estimates in Western Europe might additionally
be due to personality disorders being assessed exclusively in married
couples, although these prevalence estimates were only marginally
lower among married respondents in the remaining surveys. The
comparatively low prevalence estimates in China and Nigeria, in
comparison, are consistent with low prevalence estimates across
a wide range of disorders, raising the possibility of broad
downward bias in these surveys. In the remaining surveys, overall
personality disorder prevalence estimates were quite consistent:
between 6.1 and 7.9%.
Prevalence estimates were highest in Cluster C in the USA and
Western Europe, and highest in Cluster A in the other surveys.
Previous epidemiological surveys have, like the WMH Surveys,
been inconsistent in their estimates of the relative prevalence of
personality disorder clusters, but have generally found higher
estimates for Cluster B than in the WMH Surveys. The Cluster
B prevalence estimate is 1.5% overall and exceeds 2.0% only in
one country (Colombia) compared with a median prevalence
estimate of 5.1% in previous surveys.37 It might be that
measurement bias either in the IPDE screening questions or in
the multiple imputation procedure account for the comparatively
low Cluster B estimates.
Sociodemographic correlates of personality disorders
Our strongest finding, that Cluster A personality disorders are
much more common among men than women, is consistent with
the suggestion in the DSM–IV15 that all three Cluster A personality
disorders (paranoid, schizoid and schizotypal) are most common
among men. The insignificant association between gender and
Cluster B personality disorders, in comparison, is indirectly
consistent with the suggestion in the DSM–IV that some Cluster
B personality disorders are more common among women
(histrionic and borderline), whereas others are more common
among men (antisocial, narcissistic), with these opposite-sign
patterns possibly cancelling out in analyses at the level of the
cluster. The DSM–IV also suggests that some Cluster C personality
disorders are more common among men (obsessive–compulsive
disorder) and others among women (avoidant, dependent),
raising the possibility that our finding of a somewhat higher
prevalence of Cluster C personality disorders among men than
women reflects the former pattern dominating the latter pattern.
However, in all these cases, empirical confirmation is
impossible because too few IPDE screening questions on
personality disorders were included in the WMH Surveys to
generate reliable prevalence estimates for individual personality
disorders. This makes it difficult to compare our results with
previous studies that examined individual disorders. The fact that
neither of two recent and comparatively large community
surveys5,12 found the relatively common (compared with other
Cluster B personality disorders) category of borderline personality
disorder to be more common among women than men raises
concerns about our suggestion that opposite-sign gender
differences might cancel out in the overall prevalence of any
Cluster B personality disorder.
In comparison, our findings that young and poorly educated
people have the highest prevalence of Cluster A and B personality
disorders are consistent with a number of previous studies.10,38
Our failure to find significant inverse associations of employment
or income with personality disorders, however, is inconsistent
with the results of clinical studies.39,40 These discrepancies might
be due to ascertainment bias, base-rate differences or systematic
differences in help-seeking related to sociodemographic factors
in the clinical samples.41,42
Our finding of high comorbidity between personality disorders
and Axis I disorders is consistent with much clinical research.40 The
finding that an especially strong association exists between Cluster B
and substance use disorders is also consistent with the notion that
low impulse control is a core feature of Cluster B personality
disorders,43 and the finding of an especially strong association
between Cluster C and anxiety disorders is consistent with the
notion that characterological anxiety is the hallmark of Cluster
C personality disorders.44 Although we found low ORs of Cluster
A with Axis I disorders, stronger associations would presumably
have been found if non-affective psychoses had been assessed in
the WMH Surveys. The fact that the ORs found between clusters
and Axis I disorders are comparable in magnitude to the ORs
found between pairs of Axis I disorders45 raises the possibility that
personality disorders have been somewhat arbitrarily separated
from Axis I disorders in the DSM nomenclature.46,47
The finding that personality disorders are associated with a
wide range of functional impairments is consistent with previous
studies,48–51 as is the finding that these associations are not
accounted for by comorbid Axis I disorders,52,53 although an
earlier report of the US WMH Survey found that Axis I comorbidity
does account for the associations of personality disorders with
impairments in the USA.5 It is interesting that the associations
of personality disorders with elevated odds of help-seeking are
much more substantially reduced by controls for Axis I comorbidity
than are the ORs for measures of impairment. This suggests that
people with personality disorders seek help largely for Axis I
disorders even though most of the impairments associated with
personality disorders are not due to comorbid Axis I disorders.
Strong effects of Axis I disorders on help-seeking presumably
mean that help-seeking is based on symptoms rather than on
traits. Axis I disorders are also much more easily recognised as
illnesses needing treatment than are personality disorders because
lay illness representations exist for common Axis I disorders but
not for personality disorders.54,55
Limitations
A number of the above results are surprising, such as the findings
that Cluster A is most prevalent, that Cluster B is least prevalent
and that only Cluster C is associated with role impairment despite
being considered the least impairing cluster. These unexpected
findings raise concerns that the IPDE screening questions are
not valid in all the countries studied. We have no way to evaluate
this possibility because clinical reappraisal interviews were
administered only in the USA. Another possibility is that
concordance of screening questions with clinical diagnoses varies
across countries. Yet another possibility is that the three-cluster
model does not characterise personality disorders equally in all
countries and that a more complex specification is needed to
study these disorders cross-culturally.56 The results reported here
have to be interpreted in light of these uncertainties. Future
cross-national epidemiological studies need to address these
uncertainties by including more comprehensive assessments of
51
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personality disorders and carrying out rigorous clinical reappraisal
interviews in parallel in all participating countries.
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